Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic Dermatitis
Clinical trial NCT07683806 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07683806
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-24
- Primary completion
- 2027-06-30
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.